EU Urged To Prioritize Clinical Strategy Talks In Pre-Submission Process

 
• By Amanda Maxwell
  
EU regulatory efficiency would be improved if companies had a clinical dialogue with notified bodies Shutterstock

More from Medtech Insight

More from Policy & Regulation